Multiple subsets of HIV‐specific cytotoxic T lymphocytes in humans and in mice

Abstract

The human immunodeficiency virus type 1 (HIV‐1) induces a strong cytotoxic T lymphocyte (CTL) response in humans following infection. HIV‐specific CTL can be detected directly in the blood and lungs of infected patients, and can be expanded in vitro by stimulation with autologous HIV‐infected lymphoblasts. Furthermore, CTL specific for HIV envelope glycoprotein gp160 have been obtained in mice by immunization with recombinant vaccinia virus (VV) that carry the HIV env gene. In this study, we show that mice also produce strong CTL responses to gag and nef proteins following immunization with VV recombinants, thus providing a convenient model system to study T lymphocyte immunity to defined HIV antigens. To determine the specificity of circulating HIV‐immune CTL in humans, a panel of doubly transfected mouse P815 tumor cells was produced which express the human HLA‐A2 or HLA‐A3 transplantation antigen gene and one HIV‐1 gene (env, gag or nef). Using these cells as targets to CTL, we show that HIV‐infected humans carry co‐existing CTL sub‐populations of different specificities. Each subpopulation appears to vary in intensity among different individuals. Surprisingly, CTL specific for regulatory, non‐structural nef protein appear to be a major constituent of the human immune response to HIV.